Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A BRKRP NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score

52/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) has a negative trailing P/E of -664.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -0.15%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -664.2); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -0.15%).
Trailing Earnings Yield -0.15% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 49/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

52/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

PAST

75/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

MOAT

58/100

→ Income

GROWTH

48/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — BRKRP

Valuation Multiples

P/E (TTM)-664.2

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio2.33

P/S Ratio1.66

EV/EBITDA25.1

Per Share Data

EPS (TTM)$-0.06

Book Value / Share$16.52

Revenue / Share$22.61

FCF / Share$0.28

Yields & Fair Value

Earnings Yield-0.15%

Dividend Yield0.53%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2016	22.3	0.38	4.93	2.12	0.75%
2017	69.0	-1.46	7.40	3.07	0.47%
2018	25.9	0.20	5.14	2.45	0.54%
2019	40.1	3.84	8.72	3.82	0.32%
2020	52.6	-2.78	8.64	4.18	0.30%
2021	45.8	0.59	11.87	5.25	0.19%
2022	34.2	3.69	9.12	4.01	0.29%
2023	25.2	0.55	7.81	3.63	0.27%
2024	77.2	-1.04	4.90	2.59	0.35%
2025	-831.5	6.94	2.91	2.08	0.32%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2016	$0.95	$1.61B	$153.6M	9.5%
2017	$0.49	$1.77B	$78.6M	4.5%
2018	$1.14	$1.9B	$179.7M	9.5%
2019	$1.26	$2.07B	$197.2M	9.5%
2020	$1.02	$1.99B	$157.8M	7.9%
2021	$1.81	$2.42B	$277.1M	11.5%
2022	$1.99	$2.53B	$296.6M	11.7%
2023	$2.90	$2.96B	$427.2M	14.4%
2024	$0.76	$3.37B	$113.1M	3.4%
2025	$-0.15	$3.44B	$-8.6M	-0.3%